Prostaglandin-modulated Umbilical cord blood hematopoietic stem cell transplantation

Blood

Volumn 122, Issue 17, 2013, Pages 3074-3081

  Cutler, Corey ^a,b   Multani, Pratik ^c   Robbins, David ^c   Kim, Haesook T ^a   Le, Thuy ^c   Hoggatt, Jonathan ^b,d   Pelus, Louis M ^e   Desponts, Caroline ^c   Chen, Yi Bin ^d   Rezner, Betsy ^c   Armand, Philippe ^a   Koreth, John ^a   Glotzbecker, Brett ^a   Ho, Vincent T ^a   Alyea, Edwin ^a   Isom, Marlisa ^a   Kao, Grace ^a   Armant, Myriam ^f   Silberstein, Leslie ^b,f   Hu, Peirong ^e   Soiffer, Robert J ^a   Scadden, David T ^b,d   Ritz, Jerome ^a   Goessling, Wolfram ^a,b,g   North, Trista E ^a,b,h   Mendlein, John ^c   Ballen, Karen ^d   Zon, Leonard I ^a,b,f,i   Antin, Joseph H ^a   Shoemaker, Daniel D ^c   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c Fate Therapeutics   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e INDIANA UNIVERSITY   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; FLUDARABINE; MELPHALAN; PROSTAGLANDIN E2; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; EX VIVO STUDY; FEMALE; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL; POINT OF CARE TESTING; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REDUCED INTENSITY CONDITIONING; UMBILICAL CORD BLOOD;

EID: 84888273208     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-05-503177     Document Type: Article

References (33)

1. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321(17):1174-1178.
2. Pasquini R, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2011. http://www.cibmtr.org. 2011.
3. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344(24):1815-1822.
4. Rocha V, Labopin M, Sanz G, et al; Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351(22):2276-2285.
5. Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med. 2001;344(24):1870-1871.
6. Barker JN, Weisdorf DJ, De For TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105(3):1343-1347.
7. Kim DW, Chung YJ, Kim TG, Kim YL, Oh IH. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood. 2004;103(5):1941-1948.
8. Liu H, Rich ES, Godley L, et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood. 2011;118(24):6438-6445.
9. Frassoni F, Gualandi F, Podestà M, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol. 2008;9(9):831-839.
10. Boitano AE, Wang J, Romeo R, et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science. 2010;329(5997):1345-1348.
11. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med. 2010;16(2):232-236.
12. de Lima M, McNiece I, Robinson SN, et al. Cordblood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med. 2012;367(24):2305-2315.
13. North TE, Goessling W, Walkley CR, et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature. 2007;447(7147):1007- 1011.
14. Goessling W, Allen RS, Guan X, et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell. 2011;8(4):445-458.
15. Hoggatt J, Singh P, Sampath J, Pelus LM. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. Blood. 2009;113(22):5444-5455.
16. Goessling W, North TE, Loewer S, et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell. 2009;136(6):1136-1147.
17. Pelus LM, Hoggatt J, Singh P. Pulse exposure of haematopoietic grafts to prostaglandin E2 in vitro facilitates engraftment and recovery. Cell Prolif. 2011;44(Suppl 1):22-29.
18. Wilson DE, Quertermus J, Raiser M, Curran J, Robért A. Inhibition of stimulated gastric secretion by an orally administered prostaglandin capsule. A study in normal men. Ann Intern Med. 1976;84(6):688-691.
19. Ippoliti AF, Isenberg JI, Hagie L. Effect of oral and intravenous 16, 16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients. Gastroenterology. 1981;80(1):55-59.
20. Cutler C, Stevenson K, Kim HT, et al. Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. Bone Marrow Transplant. 2011;46(5):659-667.
21. Cutler C, Kim HT, Sun L, et al. Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. Blood. 2011;118(25):6691-6697.
22. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
23. Haspel RL, Kao G, Yeap BY, et al. Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation. Bone Marrow Transplant. 2008;41(6):523-529.
24. Avery S, Shi W, Lubin M, et al. Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood. 2011;117(12):3277-3285, quiz 3478.
25. Milano F, Heimfeld S, Gooley T, Jinneman J, Nicoud I, Delaney C. Correlation of infused CD31 CD81 cells with single-donor dominance after double-unit cord blood transplantation. Biol Blood Marrow Transplant. 2013;19(1):156-160.
26. Ramirez P, Wagner JE, De For TE, et al. Factors predicting single-unit predominance after double umbilical cord blood transplantation. Bone Marrow Transplant. 2012;47(6):799-803.
27. Delaney M, Cutler CS, Haspel RL, et al. Highresolution HLA matching in double-umbilical-cordblood reduced-intensity transplantation in adults. Transfusion. 2009;49(5):995-1002.
28. Ramirez P, Wagner JE, Defor TE, et al. CXCR4 expression in CD341 cells and unit predominance after double umbilical cord blood transplantation. Leukemia. 2013;27(5):1181-1183.
29. Brenner S, Whiting-Theobald N, Kawai T, et al. CXCR4-transgene expression significantly improves marrow engraftment of cultured hematopoietic stem cells. Stem Cells. 2004;22(7):1128-1133.
30. Liu B, Liao C, Chen J, Gu S, Wu S, Xu Z. Significance of increasing adhesion of cord blood hematopoietic cells and a new method: platelet microparticles. Am J Hematol. 2003;74(3):216-217.
31. Foudi N, Gomez I, Benyahia C, Longrois D, Norel X. Prostaglandin E2 receptor subtypes in human blood and vascular cells. Eur J Pharmacol. 2012;695(1-3):1-6.
32. Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood. 2010;115(9):1843-1849.
33. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369(9577):1947-1954.